LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026
LENSAR (Nasdaq: LNSR) will release its second quarter 2026 financial results before the market opens on Thursday, August 13, 2026.
Rhea-AI Summary
LENSAR (Nasdaq: LNSR) will release its second quarter 2026 financial results before the market opens on Thursday, August 13, 2026. Management will hold a conference call and webcast at 8:30 a.m. ET the same day to discuss results, recent developments, and strategic initiatives.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LNSR
In the Aug 6 session, LNSR declined 1.63%, reflecting a mild negative market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reporting period
- Second quarter 2026
- Financial results announcement
- Results release date
- August 13, 2026
- Before market open
- Conference call time
- 8:30 am ET
- August 13, 2026
Previous Earnings date Reports
-
Prior first-quarter results scheduling announcement preceded a negative 24-hour price reaction.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
astigmatism medical
dual-modality laser technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
ORLANDO, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s second quarter 2026 financial results will be released before market open on Thursday, August 13, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, August 13, 2026 to discuss the results, recent corporate and operational highlights and provide an update on key strategic initiatives.
To participate by telephone, please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call. The live webcast can be accessed under “Events & Presentations” in the Investor Relations section of the company’s website at https://ir.lensar.com. Following the live webcast, an archived version of the call will be available on the website.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes.
| Contacts: | Lee Roth | |
| Mike Rossi, Interim CFO | Burns McClellan for LENSAR | |
| ir.contact@lensar.com | lroth@burnsmc.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.